Material shortages make opportunity for theft

Pharmaceutical companies must pay close attention to their extended supply chains and the impact of the economy on other industries to develop strategies for dealing with raw material shortages, warns nonprofit supply chain group Rx-360. Such shortages are great opportunities for supply chain thieves to exploit. News Flash

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.